Answers are grounded in this paper and cite their sources.
Epigenetic dysregulation is triggered by environmental toxins, including heavy metals. The aberrant DNA methylation, catalyzed by DNA methyltransferases (DNMTs) in response to environmental toxins, plays a critical role in several diseases such as urinary bladder carcinogenesis. Dysregulated DNMT activity leads to genome‐wide alterations in the methylation pattern. Consequently, hypermethylation of tumor suppressor genes (TSGs) and global hypomethylation may result in genomic instability, oncogene activation, altered chromatin remodeling, and apoptosis. Although several DNMT inhibitors, including 5‐azacytidine and decitabine, are clinically approved, their instability and limited target specificity restrict their therapeutic applications. Therefore, researching novel compounds analogous to DNMT inhibitors with higher specificity may be therapeutically useful. In this context, eugenol has been found as a potential epigenetic modulator in relation to heavy metal‐induced bladder cancer; however, its underlying molecular mechanism remains obscure. To comprehend the underlying mechanism, T24 and HT1376 bladder cancer cells were treated with eugenol alone, as well as in combinations with the individual heavy metals Cr and Cd, for 72 h. The concentrations of Cr and Cd were 8 μM each for T24 cells and 1 μM Cr and 2 μM Cd for HT1376 cells. Thereafter, cytotoxicity (MTT assay), apoptosis (AO/EtBr and Annexin V‐FITC/PI), ROS generation (DCFDA), and mitochondrial membrane potential (JC‐1) were assessed. Global DNA methylation and cell migration were evaluated through Flash Global DNA Methylation analysis epi Kit and transwell migration assay, respectively. Gene and protein expressions of Bax, Bcl‐2, caspase‐9, DNMTs, p53, p21, SOCS1, p‐Akt, and NF‐κB were assessed by qPCR and western blotting, respectively. Eugenol significantly reduced viability of T24 and HT1376 cells in a dose‐dependent manner and significantly inhibited Cr‐ and Cd‐induced cell proliferation. Additionally, the treatments resulted in ROS‐associated mitochondrial depolarization, increased Bax and caspase‐9 expressions, decreased Bcl‐2 level, reduced expression of DNMTs and global DNA methylation, restoration of p53, p21 and SOCS1, suppression of p‐Akt and NF‐κB, and marked inhibition of Cd‐ and Cr‐induced migration. Together, these findings show that eugenol may emerge as a promising candidate for modulation of DNMT activity, as well as a prophylactic candidate for bladder cancer prevention and/or treatment of heavy metal‐induced bladder carcinogenesis.
No takes yet. Share an insight, caveat, or question.
Saini et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: